Ozempic compensating for Wegovy’s supply shortage due to high demand
KOLs interviewed by GlobalData have said Wegovy shows potential for the greatest amount of weight reduction in the obesity market.
Comment
AI will continue to attract investment in near future in the healthcare industry
Chinese manufacturers’ transition to innovative pharma requires more investment
Manufacturing challenges set back development progress of cell therapies in oncology
NICE to update endometriosis guidelines to improve diagnosis and surgical management
UK pharma manufacturers with US clients benefit from strengthening dollar
Novo Nordisk maintains strong growth in T2D against competitor Lilly
China’s biopharma industry: the small molecule renaissance in rare diseases
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
